Id |
Subject |
Object |
Predicate |
Lexical cue |
T593 |
116-118 |
NNP |
denotes |
WW |
T592 |
114-115 |
. |
denotes |
. |
T591 |
109-114 |
NNS |
denotes |
drugs |
T590 |
97-108 |
JJ |
denotes |
therapeutic |
T589 |
93-96 |
CC |
denotes |
and |
T588 |
91-92 |
-RRB- |
denotes |
) |
T587 |
88-91 |
NNP |
denotes |
TMZ |
T586 |
87-88 |
-LRB- |
denotes |
( |
T585 |
74-86 |
VB |
denotes |
temozolomide |
T584 |
71-73 |
TO |
denotes |
to |
T583 |
60-70 |
NN |
denotes |
resistance |
T582 |
57-59 |
TO |
denotes |
to |
T581 |
55-56 |
, |
denotes |
, |
T580 |
51-55 |
NN |
denotes |
part |
T579 |
48-50 |
IN |
denotes |
in |
T578 |
46-47 |
, |
denotes |
, |
T577 |
36-46 |
VB |
denotes |
contribute |
T576 |
33-35 |
TO |
denotes |
to |
T575 |
25-32 |
VBZ |
denotes |
appears |
T574 |
21-24 |
CC |
denotes |
and |
T573 |
19-20 |
-RRB- |
denotes |
) |
T572 |
15-19 |
NNS |
denotes |
GBMs |
T571 |
14-15 |
-LRB- |
denotes |
( |
T570 |
0-13 |
NNS |
denotes |
glioblastomas |
R284 |
T571 |
T572 |
punct |
(,GBMs |
R285 |
T572 |
T570 |
appos |
GBMs,glioblastomas |
R289 |
T576 |
T577 |
aux |
to,contribute |
R290 |
T577 |
T575 |
xcomp |
contribute,appears |
R291 |
T578 |
T577 |
punct |
",",contribute |
R292 |
T579 |
T575 |
prep |
in,appears |
R293 |
T580 |
T579 |
pobj |
part,in |
R294 |
T581 |
T575 |
punct |
",",appears |
R295 |
T582 |
T583 |
aux |
to,resistance |
R297 |
T584 |
T585 |
aux |
to,temozolomide |
R298 |
T585 |
T583 |
advcl |
temozolomide,resistance |
R299 |
T586 |
T587 |
punct |
(,TMZ |
R300 |
T587 |
T585 |
appos |
TMZ,temozolomide |
R301 |
T588 |
T587 |
punct |
),TMZ |
R302 |
T589 |
T585 |
cc |
and,temozolomide |
R303 |
T590 |
T591 |
amod |
therapeutic,drugs |
R304 |
T591 |
T585 |
conj |
drugs,temozolomide |
Id |
Subject |
Object |
Predicate |
Lexical cue |
T535 |
74-92 |
Entity |
denotes |
temozolomide (TMZ) |
T526 |
97-114 |
Entity |
denotes |
therapeutic drugs |
T523 |
88-91 |
Entity |
denotes |
TMZ |
Id |
Subject |
Object |
Predicate |
Lexical cue |
T206 |
116-118 |
JJ |
denotes |
WW |
T205 |
109-114 |
NN |
denotes |
drugs |
T204 |
97-108 |
JJ |
denotes |
therapeutic |
T203 |
93-96 |
CC |
denotes |
and |
T202 |
91-92 |
-RRB- |
denotes |
) |
T201 |
88-91 |
NN |
denotes |
TMZ |
T200 |
87-88 |
-LRB- |
denotes |
( |
T199 |
74-86 |
NN |
denotes |
temozolomide |
T198 |
71-73 |
TO |
denotes |
to |
T197 |
60-70 |
NN |
denotes |
resistance |
T196 |
57-59 |
TO |
denotes |
to |
T195 |
55-56 |
-COMMA- |
denotes |
, |
T194 |
51-55 |
NN |
denotes |
part |
T193 |
48-50 |
IN |
denotes |
in |
T192 |
46-47 |
-COMMA- |
denotes |
, |
T191 |
36-46 |
VB |
denotes |
contribute |
T190 |
33-35 |
TO |
denotes |
to |
T189 |
25-32 |
VB |
denotes |
appears |
T188 |
21-24 |
CC |
denotes |
and |
T187 |
19-20 |
-RRB- |
denotes |
) |
T186 |
15-19 |
NN |
denotes |
GBMs |
T185 |
14-15 |
-LRB- |
denotes |
( |
T184 |
0-13 |
NN |
denotes |
glioblastomas |
R49 |
T184 |
T185 |
arg1Of |
glioblastomas,( |
R50 |
T186 |
T185 |
arg2Of |
GBMs,( |
R51 |
T187 |
T185 |
arg3Of |
),( |
R52 |
T189 |
T188 |
arg2Of |
appears,and |
R53 |
T191 |
T189 |
arg2Of |
contribute,appears |
R54 |
T191 |
T190 |
arg1Of |
contribute,to |
R55 |
T191 |
T192 |
arg1Of |
contribute,"," |
R56 |
T191 |
T193 |
arg1Of |
contribute,in |
R57 |
T191 |
T195 |
arg1Of |
contribute,"," |
R58 |
T191 |
T196 |
arg1Of |
contribute,to |
R59 |
T194 |
T193 |
arg2Of |
part,in |
R60 |
T197 |
T198 |
arg1Of |
resistance,to |
R61 |
T197 |
T203 |
arg1Of |
resistance,and |
R62 |
T199 |
T198 |
arg2Of |
temozolomide,to |
R63 |
T199 |
T200 |
arg1Of |
temozolomide,( |
R64 |
T201 |
T200 |
arg2Of |
TMZ,( |
R65 |
T202 |
T200 |
arg3Of |
),( |
R66 |
T203 |
T196 |
arg2Of |
and,to |
R67 |
T205 |
T203 |
arg2Of |
drugs,and |
R68 |
T205 |
T204 |
arg1Of |
drugs,therapeutic |